ABOUT DESITIN

Desitin Pharmaceuticals GmbH – galenic innovation for over 40 years

2011 Levetiracetam Desitin
The first levetiracetam minitablets worldwide (approved administration form: film-coated granules in sachets)

2010  Sumavel^® DosePro^®
The first ready-to-use, needle free injector for sumatriptan in Europe*

2009 Topiramat Desitin quadro
The first quartered topiramate tablet worldwide

2008 Apydan extent
The first modified release formulation for oxcarbazepine worldwide

1999 Orfiril^® long 1000 mg
The first valproate administration form of this strength worldwide

1998 Orfiril^® long 150 mg / 300 mg
The first sustained-release valproate minitablets worldwide

1996 Orfiril^® solution for injection
The first ready-to-use valproate solution for injection worldwide

1984 Timonil^® 300 sustained-release
The first sustained-release formulation for carbamazepine worldwide

1978 Orfiril^® 300 sustained-release
The first sustained-release valproate formulation worldwide

1972 Phenhydan^® infusion concentrate
The first dilutable phenytoin infusion concentrate worldwide

1970 Liskantin^® syrup
The first oral administration form (liquid) for primidone worldwide

1967 Phenhydan^® solution for injection
The first ready-to-use phenytoin solution for injection worldwide

^*DosePro^TM Technology invented and owned by Zogenix, Inc.

Note: In UK Orfiril^® long and Orfiril^® solution for injection are marketed under the brand name of Episenta^®▼ (sodium valproate prolonged release) or Episenta^®▼ Solution for Injection (sodium valproate).

In the UK Levetiracetam Desitin is marketed under the brand name of Desitrend^® (levetiracetam)

None of the other products shown are available in the UK at this time from Desitin.